A Phase I Study of the Safety, Reactogenicity, and Immunogenicity of Sm-TSP-2/Alhydrogel® With or Without GLA-AF for Intestinal Schistosomiasis in Healthy Adults

NCT02337855 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

72

Enrollment

NIH

Sponsor class

Conditions

Schistosomiasis

Interventions

OTHER: Placebo
BIOLOGICAL: Sm-TSP-2/Alhydrogel
BIOLOGICAL: Sm-TSP-2/Alhydrogel/GLA-AF

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)